• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA介导的肿瘤微环境代谢重塑

MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment.

作者信息

Virga Federico, Quirico Lorena, Cucinelli Stefania, Mazzone Massimiliano, Taverna Daniela, Orso Francesca

机构信息

Molecular Biotechnology Center (MBC), University of Torino, 10126 Torino, Italy.

Department Molecular Biotechnology and Health Sciences, University of Torino, 10126 Torino, Italy.

出版信息

Cancers (Basel). 2021 Jan 3;13(1):127. doi: 10.3390/cancers13010127.

DOI:10.3390/cancers13010127
PMID:33401522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7795884/
Abstract

The metabolism of cancer cells is generally very different from what is found in normal counterparts. However, in a tumor mass, the continuous crosstalk and competition for nutrients and oxygen among different cells lead to metabolic alterations, not only in cancer cells, but also in the different stromal and immune cells of the tumor microenvironment (TME), which are highly relevant for tumor progression. MicroRNAs (miRs) are small non-coding RNAs that silence their mRNA targets post-transcriptionally and are involved in numerous physiological cell functions as well as in the adaptation to stress situations. Importantly, miRs can also be released via extracellular vesicles (EVs) and, consequently, take part in the bidirectional communication between tumor and surrounding cells under stress conditions. Certain miRs are abundantly expressed in stromal and immune cells where they can regulate various metabolic pathways by directly suppressing enzymes or transporters as well as by controlling important regulators (such as transcription factors) of metabolic processes. In this review, we discuss how miRs can induce metabolic reprogramming in stromal (fibroblasts and adipocytes) and immune (macrophages and T cells) cells and, in turn, how the biology of the different cells present in the TME is able to change. Finally, we debate the rebound of miR-dependent metabolic alterations on tumor progression and their implications for cancer management.

摘要

癌细胞的代谢通常与正常细胞有很大不同。然而,在肿瘤块中,不同细胞之间持续的串扰以及对营养物质和氧气的竞争会导致代谢改变,不仅癌细胞会发生这种改变,肿瘤微环境(TME)中不同的基质细胞和免疫细胞也会如此,而这些改变与肿瘤进展高度相关。微小RNA(miRs)是小的非编码RNA,它们在转录后使mRNA靶标沉默,并参与众多生理细胞功能以及对应激情况的适应。重要的是,miRs也可以通过细胞外囊泡(EVs)释放,因此,在应激条件下参与肿瘤细胞与周围细胞之间的双向通讯。某些miRs在基质细胞和免疫细胞中大量表达,在这些细胞中,它们可以通过直接抑制酶或转运蛋白以及控制代谢过程的重要调节因子(如转录因子)来调节各种代谢途径。在这篇综述中,我们讨论了miRs如何在基质细胞(成纤维细胞和脂肪细胞)和免疫细胞(巨噬细胞和T细胞)中诱导代谢重编程,以及反过来,TME中不同细胞的生物学特性如何发生变化。最后,我们探讨了miR依赖的代谢改变对肿瘤进展的影响及其对癌症治疗的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0833/7795884/58dc4cd1d654/cancers-13-00127-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0833/7795884/ce7bc7c4718d/cancers-13-00127-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0833/7795884/fb944e1fb079/cancers-13-00127-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0833/7795884/58dc4cd1d654/cancers-13-00127-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0833/7795884/ce7bc7c4718d/cancers-13-00127-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0833/7795884/fb944e1fb079/cancers-13-00127-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0833/7795884/58dc4cd1d654/cancers-13-00127-g003.jpg

相似文献

1
MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment.微小RNA介导的肿瘤微环境代谢重塑
Cancers (Basel). 2021 Jan 3;13(1):127. doi: 10.3390/cancers13010127.
2
Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.肿瘤微环境中癌症相关成纤维细胞和免疫细胞的代谢重编程及串扰。
Front Endocrinol (Lausanne). 2022 Aug 15;13:988295. doi: 10.3389/fendo.2022.988295. eCollection 2022.
3
Testicular germ cell tumour cells release microRNA-containing extracellular vesicles that induce phenotypic and genotypic changes in cells of the tumour microenvironment.睾丸生殖细胞肿瘤细胞释放含有 microRNA 的细胞外囊泡,这些囊泡可诱导肿瘤微环境中细胞的表型和基因型改变。
Int J Cancer. 2024 Jan 15;154(2):372-388. doi: 10.1002/ijc.34697. Epub 2023 Aug 26.
4
Metabolic crosstalk in the breast cancer microenvironment.乳腺癌微环境中的代谢串扰。
Eur J Cancer. 2019 Nov;121:154-171. doi: 10.1016/j.ejca.2019.09.002. Epub 2019 Sep 30.
5
Adipocyte, Immune Cells, and miRNA Crosstalk: A Novel Regulator of Metabolic Dysfunction and Obesity.脂肪细胞、免疫细胞和 miRNA 串扰:代谢功能障碍和肥胖的新型调节因子。
Cells. 2021 Apr 24;10(5):1004. doi: 10.3390/cells10051004.
6
Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.癌症相关成纤维细胞的代谢重编程及其对癌细胞重编程的影响。
Theranostics. 2021 Jul 13;11(17):8322-8336. doi: 10.7150/thno.62378. eCollection 2021.
7
Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment.肿瘤微环境中 microRNAs 的治疗靶向。
Int J Mol Sci. 2021 Feb 23;22(4):2210. doi: 10.3390/ijms22042210.
8
MicroRNAs and miRceptors: a new mechanism of action for intercellular communication.微小 RNA 与 miRceptors:细胞间通讯的新作用机制。
Philos Trans R Soc Lond B Biol Sci. 2018 Jan 5;373(1737). doi: 10.1098/rstb.2016.0486.
9
LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling.长链非编码 RNA 在肿瘤代谢重编程和肿瘤微环境重塑中的作用。
Front Immunol. 2024 Oct 30;15:1467151. doi: 10.3389/fimmu.2024.1467151. eCollection 2024.
10
Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy.肿瘤微环境中的代谢合作与竞争:对治疗的启示
Front Oncol. 2017 Apr 12;7:68. doi: 10.3389/fonc.2017.00068. eCollection 2017.

引用本文的文献

1
Cancer Cell-Secreted miR-33a Reduces Stress Granule Formation by Targeting Polyamine Metabolism in Stroma to Promote Tumourigenesis.癌细胞分泌的miR-33a通过靶向基质中的多胺代谢减少应激颗粒形成以促进肿瘤发生。
J Extracell Vesicles. 2025 Sep;14(9):e70153. doi: 10.1002/jev2.70153.
2
MicroRNAs in lung cancer: their role in tumor progression, biomarkers, diagnostic, prognostic, and therapeutic relevance.肺癌中的微小RNA:它们在肿瘤进展、生物标志物、诊断、预后及治疗相关性中的作用
Discov Oncol. 2025 Mar 11;16(1):293. doi: 10.1007/s12672-025-02054-9.
3
Acid affairs in anti-tumour immunity.

本文引用的文献

1
The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies.微小RNA在液体活检中作为诊断和预后生物标志物的作用。
Cancer Drug Resist. 2020 Feb 21;3(2):117-139. doi: 10.20517/cdr.2019.103. eCollection 2020.
2
miR-155 Overexpression in OT-1 CD8 T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor Antigen.OT-1 CD8 T细胞中miR-155的过表达增强了对低亲和力肿瘤抗原的抗肿瘤活性。
Mol Ther Oncolytics. 2019 Dec 25;16:111-123. doi: 10.1016/j.omto.2019.12.008. eCollection 2020 Mar 27.
3
Targeting Tumor Microenvironment by Small-Molecule Inhibitors.
抗肿瘤免疫中的酸性事件
Cancer Cell Int. 2024 Oct 27;24(1):354. doi: 10.1186/s12935-024-03520-0.
4
MicroRNAs in metabolism for precision treatment of lung cancer.代谢中的 microRNAs 用于肺癌的精准治疗。
Cell Mol Biol Lett. 2024 Sep 10;29(1):121. doi: 10.1186/s11658-024-00632-3.
5
Stroma-derived miR-214 coordinates tumor dissemination.基质衍生的 miR-214 协调肿瘤转移。
J Exp Clin Cancer Res. 2023 Jan 13;42(1):20. doi: 10.1186/s13046-022-02553-5.
6
Co-Expression of miR155 or LSD1 shRNA Increases the Anti-Tumor Functions of CD19 CAR-T Cells.共表达 miR155 或 LSD1 shRNA 可增强 CD19 CAR-T 细胞的抗肿瘤功能。
Front Immunol. 2022 Jan 3;12:811364. doi: 10.3389/fimmu.2021.811364. eCollection 2021.
7
MicroRNAs: Their Role in Metabolism, Tumor Microenvironment, and Therapeutic Implications in Head and Neck Squamous Cell Carcinoma.微小RNA:它们在头颈部鳞状细胞癌的代谢、肿瘤微环境及治疗中的作用
Cancers (Basel). 2021 Nov 9;13(22):5604. doi: 10.3390/cancers13225604.
8
Advances in the application of Let-7 microRNAs in the diagnosis, treatment and prognosis of leukemia.Let-7微小RNA在白血病诊断、治疗及预后中的应用进展
Oncol Lett. 2022 Jan;23(1):1. doi: 10.3892/ol.2021.13119. Epub 2021 Nov 2.
9
SMOX expression predicts the prognosis of non-small cell lung cancer.SMOX表达可预测非小细胞肺癌的预后。
Ann Transl Med. 2021 Jul;9(13):1048. doi: 10.21037/atm-21-998.
10
miR-940 is a new biomarker with tumor diagnostic and prognostic value.微小RNA-940是一种具有肿瘤诊断和预后价值的新型生物标志物。
Mol Ther Nucleic Acids. 2021 May 8;25:53-66. doi: 10.1016/j.omtn.2021.05.003. eCollection 2021 Sep 3.
小分子抑制剂靶向肿瘤微环境
Transl Oncol. 2020 Jan;13(1):57-69. doi: 10.1016/j.tranon.2019.10.001. Epub 2019 Nov 27.
4
T Cell Reprogramming Against Cancer.T 细胞重编程抗癌。
Methods Mol Biol. 2020;2097:3-44. doi: 10.1007/978-1-0716-0203-4_1.
5
The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment.成纤维细胞的阴暗面:肿瘤微环境中作为免疫抑制介质的癌相关成纤维细胞。
Front Immunol. 2019 Aug 2;10:1835. doi: 10.3389/fimmu.2019.01835. eCollection 2019.
6
Immunity, Hypoxia, and Metabolism-the Ménage à Trois of Cancer: Implications for Immunotherapy.免疫、缺氧与代谢:癌症的“三人行”——对免疫治疗的启示。
Physiol Rev. 2020 Jan 1;100(1):1-102. doi: 10.1152/physrev.00018.2019. Epub 2019 Aug 15.
7
Metabolic coordination of T cell quiescence and activation.T 细胞静止和激活的代谢协调。
Nat Rev Immunol. 2020 Jan;20(1):55-70. doi: 10.1038/s41577-019-0203-y. Epub 2019 Aug 12.
8
Role of miRNAs in tumor and endothelial cell interactions during tumor progression.miRNAs 在肿瘤进展过程中肿瘤细胞和内皮细胞相互作用中的作用。
Semin Cancer Biol. 2020 Feb;60:214-224. doi: 10.1016/j.semcancer.2019.07.024. Epub 2019 Aug 3.
9
The Metabolic Signature of Macrophage Responses.巨噬细胞反应的代谢特征。
Front Immunol. 2019 Jul 3;10:1462. doi: 10.3389/fimmu.2019.01462. eCollection 2019.
10
Inflammation and Cancer: Triggers, Mechanisms, and Consequences.炎症与癌症:触发因素、机制与后果。
Immunity. 2019 Jul 16;51(1):27-41. doi: 10.1016/j.immuni.2019.06.025.